TL;DR Drug Discovery is expensive and risky Cost and Risk can be lowered by more collaboration and sharing M4K Pharma is proposing Open Source Drug Discovery Don’t file patents and share all your data Academics and CRO’s start helping with development Data filed with regulatory package still allows you to have exclusivity M4K Pharma will be able to recoup costs through this exclusivity Trust between [...]
This is the second part of an interview we had the chance to do with Prof. Ernst Hafen. The first part centers around how Citizen Science can shape drug discovery and his initiative midata.coop. Listen to the podcast here. TL;DR The birth of the Bio-Technopark Schlieren shows that if innovative entrepreneurs come together with great scientists, magic can happen. Big bottleneck in translating science from [...]
TL;DR Protocols.io - a collaborative, open access platform to share scientific recipes. Scientific reproducibility is likely no worse than 30 years ago, but because of increased scrutiny and better technology now available, we are getting better at addressing it. In traditional peer review, reviewers don’t verify the working of protocols. But on protocols.io, the community has a chance to directly run the protocol and confirm [...]
This is part 1 of a longer interview with Prof. Ernst Hafen TL;DR Citizens can store their medical data on a not-for-profit service called midata.coop The service is organized as a Swiss cooperative, owned by the members Patients can share their data on a case by case basis with doctors and clinical studies This could help reduce the time & money spent to recruit patients [...]
What does bio2040 want to achieve? bio2040 is a podcast and blog created by entrepreneurs and scientists. Here you can Discover the biggest challenges in healthcare and drug discovery Meet the best cofounders, employers and candidates to tackle the challenges together What is the motivation behind bio2040? Disease is by far the largest cause of mortality and a large cause of suffering for most human [...]